Definium Therapeutics (DFTX) Stock Price & Analysis

DFTX$32.08-0.92 -2.79%
BiotechnologyGrowth Stock
Compare
Market cap$4.39BEnterprise value$4.43BRevenue (TTM)$0Market position—

Score

70
Bullish
Value
58
Quality
51
Growth
100

AI Analysis

Snapshot

Definium Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 70/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~110% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

58
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

51
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Definium Therapeutics, Inc. (DFTX) last printed $32.08. Equity value is $4.39B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

About

Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.

Definium Therapeutics (DFTX) Stock Price & Analysis

DFTX price $32.08 -0.92 -2.79%

Ticker
DFTX
Price
$32.08
Change
-0.92 -2.79%
Market cap
$4.39B
Forward P/E
33.77
Dividend yield
0.00%
Beta
2.21
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
58
Quality
51
Growth
100

Stocklytics score rationale: value 58, quality 51, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener